Replies to post #27810 on OncoSec Medical Inc (ONCSQ)

[dr_lowenstein]

The PR is rather plain and simple

This Phase II clinical trial will be conducted as a multicenter Investigator Sponsored Trial (IST), with UCSF and Dr. Alain Algazi as the sponsor. Merck will supply pembrolizumab, and OncoSec will provide electroporation devices and plasmid IL-12.